176 related articles for article (PubMed ID: 26898925)
1. Adenosine metabolism of human mesenchymal stromal cells isolated from patients with head and neck squamous cell carcinoma.
Schuler PJ; Westerkamp AM; Kansy BA; Bruderek K; Dissmann PA; Dumitru CA; Lang S; Jackson EK; Brandau S
Immunobiology; 2017 Jan; 222(1):66-74. PubMed ID: 26898925
[TBL] [Abstract][Full Text] [Related]
2. Adenosine production in mesenchymal stromal cells in relation to their developmental status.
Jeske SS; Theodoraki MN; Boelke E; Laban S; Brunner C; Rotter N; Jackson EK; Hoffmann TK; Schuler PJ
HNO; 2020 Feb; 68(2):87-93. PubMed ID: 31915882
[TBL] [Abstract][Full Text] [Related]
3. PDGF-AA mediates mesenchymal stromal cell chemotaxis to the head and neck squamous cell carcinoma tumor microenvironment.
Watts TL; Cui R; Szaniszlo P; Resto VA; Powell DW; Pinchuk IV
J Transl Med; 2016 Dec; 14(1):337. PubMed ID: 27931212
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells are enriched in head neck squamous cell carcinoma, correlates with tumour size and inhibit T-cell proliferation.
Liotta F; Querci V; Mannelli G; Santarlasci V; Maggi L; Capone M; Rossi MC; Mazzoni A; Cosmi L; Romagnani S; Maggi E; Gallo O; Annunziato F
Br J Cancer; 2015 Feb; 112(4):745-54. PubMed ID: 25647013
[TBL] [Abstract][Full Text] [Related]
5. The bidirectional tumor--mesenchymal stromal cell interaction promotes the progression of head and neck cancer.
Kansy BA; Dißmann PA; Hemeda H; Bruderek K; Westerkamp AM; Jagalski V; Schuler P; Kansy K; Lang S; Dumitru CA; Brandau S
Stem Cell Res Ther; 2014 Aug; 5(4):95. PubMed ID: 25115189
[TBL] [Abstract][Full Text] [Related]
6. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
[TBL] [Abstract][Full Text] [Related]
7. Blockade of adenosine A2A receptor enhances CD8
Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
[TBL] [Abstract][Full Text] [Related]
8. Adenosine-producing regulatory B cells in head and neck cancer.
Jeske SS; Brand M; Ziebart A; Laban S; Doescher J; Greve J; Jackson EK; Hoffmann TK; Brunner C; Schuler PJ
Cancer Immunol Immunother; 2020 Jul; 69(7):1205-1216. PubMed ID: 32146518
[TBL] [Abstract][Full Text] [Related]
9. Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer.
Mandapathil M; Szczepanski MJ; Szajnik M; Ren J; Lenzner DE; Jackson EK; Gorelik E; Lang S; Johnson JT; Whiteside TL
Clin Cancer Res; 2009 Oct; 15(20):6348-57. PubMed ID: 19825957
[TBL] [Abstract][Full Text] [Related]
10. Specific blockade CD73 alters the "exhausted" phenotype of T cells in head and neck squamous cell carcinoma.
Deng WW; Li YC; Ma SR; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Int J Cancer; 2018 Sep; 143(6):1494-1504. PubMed ID: 29663369
[TBL] [Abstract][Full Text] [Related]
11. Dual use of hematopoietic and mesenchymal stem cells enhances engraftment and immune cell trafficking in an allogeneic humanized mouse model of head and neck cancer.
Morton JJ; Keysar SB; Perrenoud L; Chimed TS; Reisinger J; Jackson B; Le PN; Nieto C; Gomez K; Miller B; Gao D; Somerset H; Wang XJ; Jimeno A
Mol Carcinog; 2018 Nov; 57(11):1651-1663. PubMed ID: 30129680
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stromal cells derived from cervical cancer produce high amounts of adenosine to suppress cytotoxic T lymphocyte functions.
de Lourdes Mora-García M; García-Rocha R; Morales-Ramírez O; Montesinos JJ; Weiss-Steider B; Hernández-Montes J; Ávila-Ibarra LR; Don-López CA; Velasco-Velázquez MA; Gutiérrez-Serrano V; Monroy-García A
J Transl Med; 2016 Oct; 14(1):302. PubMed ID: 27782859
[TBL] [Abstract][Full Text] [Related]
13. Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma.
Andrade MC; Ferreira SB; Gonçalves LC; De-Paula AM; de Faria ES; Teixeira-Carvalho A; Martins-Filho OA
Hum Immunol; 2013 Dec; 74(12):1563-74. PubMed ID: 23994583
[TBL] [Abstract][Full Text] [Related]
14. The influence of chemotherapy on adenosine-producing B cells in patients with head and neck squamous cell carcinoma.
Ziebart A; Huber U; Jeske S; Laban S; Doescher J; Hoffmann TK; Brunner C; Jackson EK; Schuler PJ
Oncotarget; 2018 Jan; 9(5):5834-5847. PubMed ID: 29464038
[TBL] [Abstract][Full Text] [Related]
15. STAT3 promotes differentiation of monocytes to MDSCs via CD39/CD73-adenosine signal pathway in oral squamous cell carcinoma.
Cui H; Lan Z; Zou KL; Zhao YY; Yu GT
Cancer Immunol Immunother; 2023 May; 72(5):1315-1326. PubMed ID: 36436019
[TBL] [Abstract][Full Text] [Related]
16. Comparative metabolic analysis in head and neck cancer and the normal gingiva.
Voelxen NF; Blatt S; Knopf P; Henkel M; Appelhans C; Righesso LAR; Pabst A; Goldschmitt J; Walenta S; Neff A; Mueller-Klieser W; Ziebart T
Clin Oral Investig; 2018 Mar; 22(2):1033-1043. PubMed ID: 28735466
[TBL] [Abstract][Full Text] [Related]
17. Exosomes in HNSCC plasma as surrogate markers of tumour progression and immune competence.
Theodoraki MN; Hoffmann TK; Jackson EK; Whiteside TL
Clin Exp Immunol; 2018 Oct; 194(1):67-78. PubMed ID: 30229863
[TBL] [Abstract][Full Text] [Related]
18. Human Mesenchymal Stromal Cells Do Not Cause Radioprotection of Head-and-Neck Squamous Cell Carcinoma.
Rühle A; Lies M; Strack M; Perez RL; Bieber B; Thomsen AR; Bronsert P; Huber PE; Hess J; Knopf A; Wuchter P; Grosu AL; Nicolay NH
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887032
[TBL] [Abstract][Full Text] [Related]
19. Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
Schrader CH; Kolb M; Zaoui K; Flechtenmacher C; Grabe N; Weber KJ; Hielscher T; Plinkert PK; Hess J
Mol Cancer; 2015 May; 14():107. PubMed ID: 25990935
[TBL] [Abstract][Full Text] [Related]
20. Identification of neuroblastoma cell lines with uncommon TAZ
Canzonetta C; Pelosi A; Di Matteo S; Veneziani I; Tumino N; Vacca P; Munari E; Pezzullo M; Theuer C; De Vito R; Pistoia V; Tomao L; Locatelli F; Moretta L; Caruana I; Azzarone B
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33452207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]